Savara Announces Participation in the H.C. Wainwright & Co. 4th Annual BioConnect Investor Conference
LANGHORNE, Pa., May 11, 2026--Savara Inc. (Nasdaq: SVRA) (the "Company"), a clinical stage biopharmaceutical company focused on rare respiratory diseases, …